JG
James A Graf
Interim CFO10% Owner

James A Graf insider trades: NKGen Biotech (NKGN) stock buys and sales

Interim CFO, NKGen Biotech Last trade Dec 4, 2023 32 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2012
5
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 4, 2023NKGN↑ Buy$2K
Nov 21, 2023NKGN↑ Buy$67
Jun 1, 2021GFOR↑ Buy$50K
May 27, 2021GFOR↑ Buy$5K
May 25, 2021GFOR↑ Buy$13K
Feb 27, 2019EAGL↑ Buy$10K
Mar 2, 2015EAGL↓ Sell$8
Jul 10, 2013EAGL↓ Sell$11
May 8, 2012EAGL↑ Buy$5

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James A Graf's insider trades

James A Graf is Interim CFO at NKGen Biotech (NKGN). Since May 8, 2012, James has reported 7 open-market purchases worth $80K and 2 sales worth $19 on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (20 filings), grants and awards (5 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NKGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.